An Attentional Bias Modification Task, through Virtual Reality and Eye-Tracking Technologies, to Enhance the Treatment of Anorexia Nervosa.
Franck-Alexandre Meschberger-AnnweilerMariarca AscioneBruno Porras-GarciaMarta Ferrer GarciaManuel Moreno-SanchezHelena Miquel-NabauEduardo Serrano TroncosoMarta Carulla-RoigJosé Gutiérrez-MaldonadoPublished in: Journal of clinical medicine (2023)
Mirror exposure therapies (METs) have been shown to be effective in reducing body image disturbances through the habituation process. Virtual reality (VR) combined with eye-tracking techniques can provide innovative solutions to some of METs' limitations reported with patients with anorexia nervosa (AN), especially the negative influence of body-related attentional bias (AB). This pilot study aimed to assess the preliminary efficacy of a new VR-based AB modification task (ABMT) among healthy women and the procedure's user experience. AB levels towards weight- and non-weight-related body parts, using complete fixation time (CFT) and number of fixations (NF), were assessed throughout the ABMT procedure (300 trials). The user experience was evaluated at the end of the procedure. The results showed that VR-based ABMT was effective in reducing AB significantly after 150 trials for both CFT- and NF-based measures, although 225 trials were necessary to get the same result for women with an NF initially more oriented towards weight-related body parts. Overall, the software received a "C-rating" on a scale from "A" (most usable) to "F" (least usable). These results provide evidence of the opportunity to use a VR-based ABMT procedure to reduce AB and improve existing treatments for AN.
Keyphrases
- virtual reality
- anorexia nervosa
- minimally invasive
- signaling pathway
- lps induced
- weight loss
- physical activity
- body mass index
- oxidative stress
- nuclear factor
- working memory
- pi k akt
- weight gain
- inflammatory response
- polycystic ovary syndrome
- toll like receptor
- insulin resistance
- type diabetes
- skeletal muscle
- immune response
- replacement therapy